The interpretation of radiogenomic findings and its biological or clinical meaning is currently discussed and still unknown. Therefrom, a translational approach is aimed for integration of laboratory investigations and radiogenomic findings resulting in meaningful integration of radiogenomic discoveries. The presented study aimed to explore the molecular background of a MR-Spectroscopy imaging. In a stepwise approach findings were validated on tissue samples and finally taken into glioma cell models.
This abstract and the presentation materials are available to members only; a login is required.